EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer

Ana Rita Simoes iD, Silvia Carlés González, María Del Carmen Lopez-Doldan, Goretti Duran, Ana Fernández-Montes, Maria Perfecta Fernandez, Mercedes Salgado Fernandez, Jesus Garcia Mata, David Paez, Pau Riera, Elisabeth Guino, Luis Lopez-Fernandez und 9 weitere

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.70051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Ana Rita Simoes und 20 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Chemotherapeutic treatment for colorectal cancer (colorectal cancer) allows for increased patient overall survival. However, current therapeutic regimens are often associated with the development of adverse drug reactions, which represent a morbidity, mortality and economic issue. We propose to identify novel germline markers that allow us to predict adverse drug reactions development after colorectal cancer chemotherapy. Experimental Approach For that purpose, we selected 163 colorectal cancer patients with severe adverse drug reactions (CTCAE grades 3–4) and 52 controls and applied whole‐exome sequencing (WES) to discover novel germline toxicity variants. Key Results We found 13 cases carrying actionable dihydropyrimidine dehydrogenase gene ( DPYD ) variants and a novel, potentially pathogenic DPYD variant – c.2071G > T, p.(V691L), rs202212118. Moreover, we found 30 novel rare, high‐impact variants in 14 reported genes. We also identified seven patients carrying more than one variant in the same gene or pathway, with one patient hinting at a potential digenic inheritance. Using an exome‐wide approach, we discovered and independently validated three novel candidate toxicity genes ( ALDH9A1 , FAM83A and EPX ). Gene‐based analyses also provided 14 genes significantly associated with neuropathy, skin toxicity and cardiotoxicity. Conclusions and Implications Overall, the present work has utilised state‐of‐the‐art approaches to uncover several novel candidate toxicity variants/genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAntineoplastic AgentsHumansMaleFemaleAgedMiddle AgedDihydrouracil Dehydrogenase (NADP)Exome SequencingPharmacogeneticsAdult

Stichwörter der Autor:innen

adverse drug reactionscolorectal cancerpersonalised medicinepharmacogenomics

Substanzen

Antineoplastic AgentsDihydrouracil Dehydrogenase (NADP)

Autor:innen und Institutionen

  • Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.
  • Oncological Pharmacy Unit, Complexo Hospitalario Universitario de Ourense, Ourense, Spain.
  • University Hospital of Santiago de Compostela Pharmacy Service, Santiago de Compostela, Spain.
  • Medical Oncology Unit, Complexo Hospitalario Universitario de Ourense, Ourense, Spain.
  • Hospital de la Santa Creu i Sant Pau, Medical Oncology Department, Barcelona, Spain.
  • Institut d'Investigacio Biomedica Sant Pau, Translational Medical Oncology Laboratory, Barcelona, Spain.

ORCID-Profile: Ana Rita Simoes

Zitieren

APA

Simoes, A. R., Carlés González, S., Lopez-Doldan, M. D. C., Duran, G., Fernández-Montes, A., Fernandez, M. P., Salgado Fernandez, M., Garcia Mata, J., Paez, D., Riera, P., Guino, E., Lopez-Fernandez, L., Garcia de Santiago, B., López Aspiroz, E., Rojas, A., Castells, A., Castellvi-Bel, S., Ruiz Ponte, C., Vymetalkova, V., …, & Fernandez-Rozadilla, C. (2025). Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer. British Journal of Pharmacology. https://doi.org/10.1111/bph.70051

Vancouver

Simoes AR, Carlés González S, Lopez-Doldan MDC, Duran G, Fernández-Montes A, Fernandez MP, et al. Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer. British Journal of Pharmacology. 2025. doi:10.1111/bph.70051

BibTeX
@article{Simoes2025,
  author = {Simoes, Ana Rita and Carlés González, Silvia and Lopez-Doldan, María Del Carmen and Duran, Goretti and Fernández-Montes, Ana and Fernandez, Maria Perfecta and Salgado Fernandez, Mercedes and Garcia Mata, Jesus and Paez, David and Riera, Pau and Guino, Elisabeth and Lopez-Fernandez, Luis and Garcia de Santiago, Belen and López Aspiroz, Elena and Rojas, Augusto and Castells, Antoni and Castellvi-Bel, Sergi and Ruiz Ponte, Clara and Vymetalkova, Veronika and Carracedo, Angel and Fernandez-Rozadilla, Ceres},
  title = {Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.70051}
}
Kostenlos starten →